The acquisition is the first of several planned to support the company’s process technology platform
ChargePoint Technology has been acquired by Arcline Investment Management. The deal will see ChargePoint Technology, headquartered in Liverpool, UK, become part of Arcline’s broader speciality process technologies platform offering.
Working with Arcline, ChargePoint will further accelerate its product development pipeline, including enhanced sterile & contained process solutions.
ChargePoint is expected to be the first of several acquisitions to support Arcline’s process technology platform, providing it with sterile and contained powder transfer equipment, such as its single-use powder transfer bags and split-butterfly valves (SBVs).
Arcline said: “We are excited to become part of the ChargePoint Technology story and to partner with the ChargePoint team to support the global production of medicines.
“ChargePoint Technology has an impressive product portfolio, and an incredible and visionary team of technical experts. Together, we believe we will be able to create and deliver a truly cutting-edge technology platform that will transform pharma & biopharma processing, benefiting both ChargePoint’s customers and ultimately the patients relying on their products.”
The investment will allow the business to increase and deepen its local presence in key European, American and Asian markets. A broader global presence will enable ChargePoint to offer its customers increased localised support, tailored to the needs of their business to help them navigate challenges in their local markets.
Chris Eccles, CEO at ChargePoint Technology, said: “Partnering with Arcline is an incredible opportunity for us to further strengthen our commitment to delivering high-quality world class process solutions for our customers.”